2
Registered trials
0
Recruiting
2
Unique sponsors
2
Unique IMPs
2
Commercial trials
Drug classes (ATC)
N
Neurology/Psychiatry (ATC N)
1
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Phase III:
1
Phase II:
1
Phase III
1 trial-
EndedSalix Pharmaceuticals Inc. CommercialRIFAXIMIN
Phase II
1 trial-
EndedVersantis AG CommercialCITRIC ACID, ANHYDROUS PH. EUR.
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Versantis AG | Commercial | 1 | Phase II | 0 |
| Salix Pharmaceuticals Inc. | Commercial | 1 | Phase III | 0 |
New trials by year
2024
1
2025
1